Europe – EU pharmaceutical policy: MEPs support comprehensive reform

On Tuesday, the Environment, Public Health and Food Safety Committee adopted its position on the new directive (66 votes in favour, two against and...

USA – FDA wants feedback on testing methods for new nitrosamines

The US Food and Drug Administration (FDA) is requesting stakeholder input on approaches for identifying and testing novel nitrosamines identified in drug products and...

USA – QTc: FDA proposes labeling for heart drugs with heart rhythm risk

The US Food and Drug Administration (FDA) on Monday issued draft guidance offering recommendations for sponsors to include labeling information on QTc interval prolongation...

Europe – EMA recommendation paper: Safety, data integrity key to decentralized trial conduct

The European Medicines Agency (EMA), European Commission (EC), and Heads of Medicines Agencies (HMA) recently acknowledged the growing role of decentralized elements in the...
Advice for Management of Clinical trials in relation to Coronavirus

UK – SKYCovion COVID-19 vaccine authorised by MHRA

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). It becomes the 8th...

USA – FDA revises guidance on responding to ANDA complete response letters

The US Food and Drug Administration (FDA) has revised its guidance on timeframes for responding to complete response letters (CRL) to abbreviated new drug...

France – Forfait innovation : une 1ère technologie de santé inscrite au remboursement par...

Mis en place en 2009 et piloté par le ministère chargé de la santé, le forfait innovation est un dispositif dérogatoire et temporaire de...

USA – Comparability protocols: Final guidance incorporates ICH Q12, allows for API supplier changes

The US Food and Drug Administration’s (FDA) last week released a final guidance to assist the pharmaceutical industry in submitting comparability protocols for postapproval...

UK – NICE approval for Janssen’s Darzalex combination

Recommendation concerns routine use across the NHS as therapy for multiple myeloma The Janssen Pharmaceutical Companies of Johnson & Johnson have announced that the National...

Europe – Experts outline challenges of combination products in Europe

Combination products are increasingly important, increasingly complex and are increasing the pressure on the European regulatory network, according to Thomas Wejs Møller, senior director...